GlassScriptPhysician profile
Evan P Cohen
NPI 1033447636
$5,987.11
in general payments reported to CMS, 2019-2025
17 companies · $353 in 2025
The $353 reported for 2025 was more than what 90% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $120 · 2021: $520 · 2022: $363 · 2023: $1,236 · 2024: $3,055 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,893 · Travel and Lodging: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,893.24 |
| Travel and Lodging | $750.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,298.08 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $528.90 | 2023-2024 | Proclaim, Penta, Octrode |
| Astrazeneca Pharmaceuticals LP | $472.18 | 2019-2024 | Andexxa |
| Pfizer INC. | $376.80 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $364.67 | 2020-2024 | Xarelto |
| Chiesi USA, INC. | $340.03 | 2020-2022 | |
| Daiichi Sankyo INC. | $125.00 | 2019 | |
| Fisher & Paykel Healthcare INC | $100.16 | 2023 | Fisher & Paykel Healthcare |
| Portola Pharmaceuticals, LLC | $91.87 | 2019 | |
| Inari Medical, INC. | $80.46 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ethicon US, LLC | $64.15 | 2023 | Dermabond, Stratafix |
| Aero US INC | $45.98 | 2024 | Aerogen Solo Nebulizer System, Aerogen Solo; Aerogen Ultra, Aerogen Usb Controller System |
| Ceribell, INC. | $26.49 | 2024 | Pocket Eeg Device |
| Convatec INC. | $21.52 | 2024 | |
| Gilead Sciences, INC. | $20.19 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.62 | 2024 | |
| Purdue Pharma L.P. | $15.01 | 2023 | Nalmefene Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.